Open access · CC-BY
via OpenAlex
Early and intermediate age-related macular degeneration: update and clinical review
Alfredo García‐Layana, Francisco Antonio Cabrera López, José García‐Arumí, Luís Arias, José M. Ruiz‐Moreno
Clinical Interventions in Aging · 2017 · ▲ 187 citations
Abstract
Age-related macular degeneration (AMD) is the leading cause of irreversible central vision loss in developed countries. With the aging of population, AMD will become globally an increasingly important and prevalent disease worldwide. It is a complex disease whose etiology is associated with both genetic and environmental risk factors. An extensive decline in the quality of life and progressive need of daily living assistance resulting from AMD among those most severely affected highlights the essential role of preventive strategies, particularly advising patients to quit smoking. In addition, maintaining a healthy diet, controlling other risk factors (such as hypertension, obesity, and atherosclerosis), and the use of nutritional supplements (antioxidants) are recommendable. Genetic testing may be especially important in patients with a family history of AMD. Recently, unifying criteria for the clinical classification of AMD, defining no apparent aging changes; normal aging changes; and early, intermediate, and late AMD stages, are of value in predicting AMD risk of progression and in establishing recommendations for the diagnosis, therapeutic approach, and follow-up of patients. The present review is focused on early and intermediate AMD and presents a description of the clinical characteristics and ophthalmological findings for these stages, together with algorithms for the diagnosis and management of patients, which are easily applicable in daily clinical practice.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.2147/cia.s142685
- Canonical
- link ↗
- Fetched
- 2026-11-13 MST
Cite this
APA
García‐Layana, A., López, F.A.C., García‐Arumí, J., Arias, L., & Ruiz‐Moreno, J.M. (2017). Early and intermediate age-related macular degeneration: update and clinical review. <em>Clinical Interventions in Aging</em>. https://doi.org/10.2147/cia.s142685
Vancouver
García‐Layana A, López FAC, García‐Arumí J, Arias L, Ruiz‐Moreno JM. Early and intermediate age-related macular degeneration: update and clinical review. Clinical Interventions in Aging. 2017. doi:10.2147/cia.s142685.
BibTeX
@article{alfredo2017Earlya,
title = {Early and intermediate age-related macular degeneration: update and clinical review},
author = {Alfredo García‐Layana and Francisco Antonio Cabrera López and José García‐Arumí and Luís Arias and José M. Ruiz‐Moreno},
journal = {Clinical Interventions in Aging},
year = {2017},
doi = {10.2147/cia.s142685},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Clinical Genetics 2013
Open access · CC-BY
Age‐related macular degeneration—clinical review and genetics update
Molecular Interventions 2010
Preprint · OA
Age-related Macular Degeneration: Genetic and Environmental Factors of Disease
Nursing 2024
Citation only
Age-related macular degeneration
Clinical Interventions in Aging 2008
Open access · CC-BY
Age-related macular degeneration and the aging eye
Deutsches Ärzteblatt international 2020
Preprint · OA
The Diagnosis and Treatment of Age-Related Macular Degeneration
University of Udine 2024
Open access · US-GOV